104 related articles for article (PubMed ID: 9854217)
1. [Ischemic colitis after taking flutamide].
Barouk J; Doubremelle M; Faroux R; Schnee M; Lafargue JP
Gastroenterol Clin Biol; 1998 Oct; 22(10):841. PubMed ID: 9854217
[No Abstract] [Full Text] [Related]
2. [Fulminant hepatitis associated with treatment with flutamide].
García-Gascó P; Morata Aldea C; Segura Huertas A; Aparicio Urtasun J
Med Clin (Barc); 1997 Dec; 109(20):820. PubMed ID: 9493166
[No Abstract] [Full Text] [Related]
3. [Experience with therapy of prostate cancer in the Primorye Territory].
Gurina LI; Iudin SV
Vopr Onkol; 2004; 50(5):599-601. PubMed ID: 15715105
[TBL] [Abstract][Full Text] [Related]
4. Flutamide-induced photosensitivity: is it a forme fruste of lupus?
Kaur C; Thami GP
Br J Dermatol; 2003 Mar; 148(3):603-4. PubMed ID: 12653768
[No Abstract] [Full Text] [Related]
5. [Toxic hepatitis after flutamide treatment].
Bengoechea Gallastegui L; Vita Garay A; Castiella Eguzkiza A; Egido Arroyo JF
Aten Primaria; 2005 Jun; 36(2):112. PubMed ID: 15989835
[TBL] [Abstract][Full Text] [Related]
6. [Hepatoxicity caused by flutamide increased by hypotensive situation?].
Serrano Hernández N; García López F; Fedriani Gorria J
An Med Interna; 1996 Nov; 13(11):552-4. PubMed ID: 9019217
[TBL] [Abstract][Full Text] [Related]
7. Male breast adenocarcinoma in a prostate cancer patient following prolonged anti-androgen monotherapy.
Karamanakos P; Mitsiades CS; Lembessis P; Kontos M; Trafalis D; Koutsilieris M
Anticancer Res; 2004; 24(2C):1077-81. PubMed ID: 15154626
[TBL] [Abstract][Full Text] [Related]
8. Re: Quality of life in advanced prostate cancer: results of a randomized therapeutic trial.
Albertsen PC
J Natl Cancer Inst; 1999 Apr; 91(7):646. PubMed ID: 10203286
[No Abstract] [Full Text] [Related]
9. Watchful waiting beats androgen deprivation therapy in early prostate cancer.
Brower V
J Natl Cancer Inst; 2008 Nov; 100(21):1494-6. PubMed ID: 18957680
[No Abstract] [Full Text] [Related]
10. Flutamide-induced acute hepatitis: investigation on the role of immunoallergic mechanisms.
Pontiroli L; Sartori M; Pittau S; Morelli S; Boldorini R; Albano E
Ital J Gastroenterol Hepatol; 1998 Jun; 30(3):310-4. PubMed ID: 9759603
[TBL] [Abstract][Full Text] [Related]
11. The effects of combined androgen blockade on cognitive function during the first cycle of intermittent androgen suppression in patients with prostate cancer.
Cherrier MM; Rose AL; Higano C
J Urol; 2003 Nov; 170(5):1808-11. PubMed ID: 14532781
[TBL] [Abstract][Full Text] [Related]
12. Vitiliginous lesions after photosensitive dermatitis due to flutamide.
Swoboda A; Kasche A; Baumstark J; Worret WI; Ring J; Eberlein-König B
J Eur Acad Dermatol Venereol; 2007 May; 21(5):681-2. PubMed ID: 17447984
[No Abstract] [Full Text] [Related]
13. Widespread vitiligo after erythroderma caused by photosensitivity to flutamide.
Rafael JP; Manuel GG; Antonio V; Carlos MJ
Contact Dermatitis; 2004 Feb; 50(2):98-100. PubMed ID: 15128321
[No Abstract] [Full Text] [Related]
14. Flutamide photosensitivity.
Tsien C; Souhami L
J Urol; 1999 Aug; 162(2):494. PubMed ID: 10411069
[No Abstract] [Full Text] [Related]
15. Flutamide induced methemoglobinemia.
Khan AM; Singh NT; Bilgrami S
J Urol; 1997 Apr; 157(4):1363. PubMed ID: 9120948
[No Abstract] [Full Text] [Related]
16. [Fatal hepatic failure following hepatitis caused by flutamide: a case report].
Okaneya T; Murata Y; Kinebuchi Y
Nihon Hinyokika Gakkai Zasshi; 1999 May; 90(5):590-3. PubMed ID: 10386060
[TBL] [Abstract][Full Text] [Related]
17. Randomized trial of leuprorelin and flutamide in male patients with hepatocellular carcinoma treated with tamoxifen.
Groupe d'Etude et de Traitement du Carcinome Hépatocellulaire
Hepatology; 2004 Dec; 40(6):1361-9. PubMed ID: 15565568
[TBL] [Abstract][Full Text] [Related]
18. [Fulminant liver failure induced by flutamide].
Rodríguez Gómez SJ; Martínez Moreno J; Martín Arribas MI; Pérez Villoria A; De la Serna Higuera C; Betancourt González A
Rev Esp Enferm Dig; 2000 Jun; 92(6):411. PubMed ID: 10985104
[No Abstract] [Full Text] [Related]
19. Testosterone suppression in men with prostate cancer is associated with increased arterial stiffness.
Dockery F; Bulpitt CJ; Agarwal S; Rajkumar C
Aging Male; 2002 Dec; 5(4):216-22. PubMed ID: 12630068
[TBL] [Abstract][Full Text] [Related]
20. Androgen deprivation in men with prostate cancer is associated with an increased rate of bone loss.
Preston DM; Torréns JI; Harding P; Howard RS; Duncan WE; McLeod DG
Prostate Cancer Prostatic Dis; 2002; 5(4):304-10. PubMed ID: 12627216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
